COVID-19-associated pulmonary aspergillosis (CAPA): Risk factors and development of a predictive score for critically ill COVID-19 patients
Publisher
WileyDate
2022-02-25Citation
10.1111/myc.13434
Mycoses 65.5 (2022): 541-550
ISSN
0933-7407 (print); 1439-0507 (online)DOI
10.1111/myc.13434Editor's Version
https://doi.org/10.1111/myc.13434Subjects
CAPA; COVID-19; Critically ill; Score; MedicinaRights
© 2022 The Authors
Esta obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.
Abstract
Background: COVID-19-associated pulmonary aspergillosis (CAPA) is a major complication of critically ill COVID-19 patients, with a high mortality rate and potentially preventable. Thus, identifying patients at high risk of CAPA would be of great interest. We intended to develop a clinical prediction score capable of stratifying patients according to the risk for CAPA at ICU admission. Methods: Single centre retrospective case–control study. A case was defined as a patient diagnosed with CAPA according to 2020 ECMM/ISHAM consensus criteria. 2 controls were selected for each case among critically ill COVID-19 patients. Results: 28 CAPA patients and 56-matched controls were included. Factors associated with CAPA included old age (68 years vs. 62, p =.033), active smoking (17.9% vs. 1.8%, p =.014), chronic respiratory diseases (48.1% vs. 26.3%, p =.043), chronic renal failure (25.0% vs. 3.6%, p =.005), chronic corticosteroid treatment (28.6% vs. 1.8%, p <.001), tocilizumab therapy (92.9% vs. 66.1%, p =.008) and high APACHE II at ICU admission (median 13 vs. 10 points, p =.026). A score was created including these variables, which showed an area under the receiver operator curve of 0.854 (95% CI 0.77-0.92). A punctuation below 6 had a negative predictive value of 99.6%. A punctuation of 10 or higher had a positive predictive value of 27.9%. Conclusion: We present a clinical prediction score that allowed to stratify critically ill COVID-19 patients according to the risk for developing CAPA. This CAPA score would allow to target preventive measures. Further evaluation of the score, as well as the utility of these targeted preventive measures, is needed
Files in this item
Google Scholar:Calderón Parra, Jorge
-
Mills Sanchez, Patricia
-
Moreno Torres, Victor
-
Tejado Bravo, Sandra
-
Romero Sánchez, Isabel
-
Balandin Moreno, Bárbara
-
Calvo Salvador, Marina
-
Portero Azorín, Francisca
-
García Masedo, Sarela
-
Muñez Rubio, Elena
-
Ramos Martínez, Antonio
-
Fernández Cruz, Ana
This item appears in the following Collection(s)
Related items
Showing items related by title, author, creator and subject.
-
Systemic Autoimmune Diseases in Patients Hospitalized with COVID-19 in Spain: A Nation-Wide Registry Study
Moreno-Torres, Víctor; de Mendoza, Carmen; Mellor-Pita, Susana; Martínez-Urbistondo, María; Durán-del Campo, Pedro; Tutor-Ureta, Pablo; Vázquez-Comendador, José Manuel; Calderón-Parra, Jorge; Múñez-Rubio, Elena; Ramos-Martínez, Antonio; Fernández-Cruz, Ana; Castejón, Raquel; Vargas Núñez, Juan Antonio
2022-07-26 -
Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study
Sánchez-Guijo, Fermín; García Arranz, Mariano Andrés; López-Parra, Miriam; Monedero, Pablo; Mata-Martínez, Carmen; Santos, Arnoldo; Sagredo, Víctor; Alvarez-Avello, José Manuel; Guerrero, José Eugenio; Pérez-Calvo, César; Sánchez-Hernández, Miguel Vicente; Del-Pozo, José Luis; Andreu, Enrique J.; Fernández-Santos, María Eugenia; Soria-Juan, Barbara; Hernández-Blasco, Luis M.; Andreu, Etelvina; Sempere, José M.; Zapata, Agustín G.; Moraleda, José M.; Soria, Bernat; Fernández-Avilés, Francisco; García Olmo, Damián
; Prósper, Felipe
2020-07-10